Navigation Links
SYNTAX Substudy Shows Positive Outcomes for Left Main Patients Treated With TAXUS(R) Express2(R) Stent System
Date:5/19/2009

NATICK, Mass. and BARCELONA, Spain, May 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive outcomes from a substudy of patients with left main coronary disease who were treated with the TAXUS(R) Express2(R) Paclitaxel-Eluting Coronary Stent System. SYNTAX-LE MANS is a substudy of the landmark SYNTAX trial, the first randomized, controlled clinical trial to compare percutaneous coronary intervention (PCI) using the TAXUS Stent to coronary artery bypass graft (CABG) surgery in patients with left main disease and/or significant narrowing of all three coronary arteries (three-vessel disease). The substudy data were presented by A. Pieter Kappetein, M.D., Ph.D., at the annual EuroPCR Scientific Program in Barcelona.

SYNTAX-LE MANS compares late angiographic and clinical outcomes in 263 patients with left main disease (149 treated with the TAXUS Stent and 114 treated with CABG). It is designed to assess 15-month patency (vessel openness) and the safety of stents and grafts in this high-risk population; it includes separate primary endpoints for each treatment arm. For PCI patients, the primary endpoint is the rate of long-term patency (defined here as <50% stenosis) of the treated lesion sites. For CABG patients, the primary endpoint is the ratio of obstructed/occluded grafts (defined here as greater than or equal to 50% stenosis) to total placed grafts. Results were presented separately for each group, and no formal statistical inferences between the two groups were made due to the different primary endpoints. Results were also broken out by left main lesion location, including distal and non-distal.

For those patients receiving a TAXUS Stent, the patency rate for the treated lesion was 92 percent. Restenosis was more common with distal lesions (90% patency) compared with non-distal
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. SYNTAX defines borders between CABG and PCI with TAXUS drug-eluting stents
2. State Audit of Blue Cross Blue Shield of Michigan Shows Company in Compliance with State and National Accounting Guidelines
3. McGraw Wentworth Mid-Market Group Benefits Survey Shows Health Care Costs Increasing at 6-Year Low of 5%
4. Autism in the UK costs more than $41 billion every year, shows new research
5. Sodium channel blocker shows promise as a potential treatment for cystic fibrosis
6. Transplant patients have worse cancer outcomes, analysis shows
7. Long-term study shows low oxygen levels in prostate tumors can predict recurrence
8. U.S. Study Shows Significant Improvement for Patients Suffering from Excessive Sweating with Topical Antiperspirant
9. New Discovery Shows Ancient Herb Fights Inflammation
10. Study shows chemotherapy improves survival among older breast cancer patients
11. UCLA study shows traumatic brain injury haunts children for years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... has shown that cancer cells have a much different ... Now, scientists at The University of Texas at Dallas ... new strategy to combat lung cancer. , In an ... PLOS ONE , UT Dallas researchers compared the metabolic ... cells taken from the same patient. , They ...
(Date:6/18/2013)... The July 2013 issue of Marie Claire magazine in ... offers a list of home and doctor’s office treatments to ... suit this summer. The list includes treatment options for ... , and more. (go to goo.gl/aIe4J). , “It’s a helpful ... Hills, “though I would say some of the advice offered ...
(Date:6/18/2013)... Destin, FL (PRWEB) June 18, 2013 ... coast by storm. The burgeoning aquaculture industry is redefining ... Jekyll, one of the most acclaimed personal culinary chefs ... his clientele on benefits of sustainable seafood and the ... used in abundance these days. Many consumers strive to ...
(Date:6/18/2013)... By studying one of the most successful ... of successful strategies in his article What We Can ... Study. , The inspirational brand Gollan refers to is ... an impressive 62 million followers (and rising). , The ... Facebook Pages earlier this year. The Facebook data tracking publication ...
(Date:6/18/2013)... June as Lesbian, Gay, Bisexual and Transgender ... civil rights, sexual minority youth are still ... heterosexual peers, according to the Suicide Prevention ... graduate student recently published recommendation to improve ... could help improve psychological functioning and reduce ...
Breaking Medicine News(10 mins):Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Skin Care – Getting Your Body Beach Ready 2Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 3Health News:Sexual minority youth need specialized treatment from therapists 2
... University of California, San Diego (UCSD) School of Medicine ... that, 30 years ago, a virus infected the strep ... bacteria that has evolved to produce serious human infections ... has risen dramatically in the last three decades, and ...
... ride of Dr.Mohammed Haneef, the man from Bangalore in southern ... a heavy price for a small act of indiscretion, it looks ... his cousins, the key players in the failed Glasgow bombing. ... India, two days after the Glasgow incident, Haneef has been seeing ...
... found that symptoms in patients with obstructive sleep apnea ... with nasal insufflation (TNI), using a nasal cannula to ... ,Our findings provide evidence that TNI may ... hypopneas and apneas, said lead researcher Hartmut Schneider, M.D., ...
... 5 in North Yorkshire, troubled rocker Pete Doherty got into ... . , ,The Babyshambles singer boarded a blue ... they spotted him chucking garbage out of the window in ... troubled rocker looked really sheepish and embarrassed, and that the ...
... follow, the Varanavasi Village Panchayat near Kanchipuram in Tamil ... villagers . ,Aghast over an ever-increasing trend ... resolution to ban the entry and consumption of tobacco ... started consuming tobacco products like cigarette and gutka. Hence, ...
... Leading US drug manufacturer, Jazz Pharmaceuticals, has agreed to ... claims that one of its subsidiaries illegally marketed ... ,Narcolepsy is a sleep disorder marked by sudden, uncontrollable ... at inappropriate times. ,,The case is the ...
Cached Medicine News:Health News:Key Mechanism to Emergence of Strep Bacteria 2Health News:Key Mechanism to Emergence of Strep Bacteria 3Health News:Haneefs Visa Revoked by Australia 2Health News:Nasal Cannula Treatment for Sleep Apnea Patients 2Health News:Nasal Cannula Treatment for Sleep Apnea Patients 3Health News:Village Panchayat in Tamil Nadu Bans Tobacco Consumption 2Health News:Manufacturer to Pay $20 Million for Improperly Promoting a Sleep Disorder Drug 2Health News:Manufacturer to Pay $20 Million for Improperly Promoting a Sleep Disorder Drug 3
(Date:6/18/2013)... CHAPEL HILL, N.C. , June 18, 2013 /PRNewswire/ ... and more difficult for Medical Education groups at large ... practitioners on the safe and effective use of their ... within the pharma industry, it is crucial that these ... of reaching healthcare professionals. To address the ...
(Date:6/18/2013)... , June 18, 2013 Unilife Corporation ("Unilife" ... designer, developer and manufacturer of injectable drug delivery systems, ... at www.unilife.com . The new site includes additional ... to occur on a regular basis. Mr. ... "As an emerging global leader for injectable drug delivery ...
(Date:6/18/2013)... 18, 2013  Specialty Coating Systems is ... Parylene coating technologies: SCS microRESIST™ Antimicrobial Parylene ... Parylene with antimicrobial properties to effectively eliminate ... (Logo: http://photos.prnewswire.com/prnh/20130618/DE33772LOGO ) ... and continue to pose a challenge to ...
Breaking Medicine Technology:Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2Unilife Launches New Corporate Website 2Specialty Coating Systems Announces New Antimicrobial Parylene Technology 2
... March 5 A study published by Deborah ... the Journal of Drugs in Dermatology ... resurfacing technologies, specifically, the SmartXide DOT(TM) laser. DOT utilizes ... for rapid healing, less downtime and profound results. Dr. ...
... Complications Reported With Coronary DeviceDOYLESTOWN, Pa., March 4 ... in February by completing the enrollment of 30 ... clinical trial for the vProtect(TM) Luminal Shield, conducted ... Shield successfully crossed all target lesions and was ...
Cached Medicine Technology:New Study Published in the Journal of Drugs in Dermatology Finds DOT Microablative CO2 Laser Optimum for Skin Rejuvenation 2Prescient Medical Achieves Milestones in Clinical Studies of vProtect(TM) Luminal Shield 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: